To determine whether CD162 plays a role in AML chemo-sensitivity, we repeated a transplant of WT or Selplg–/– MLL-AF9 AML blasts in wildtype hosts and investigated whether Selplg–/– AML blasts were more sensitive to chemotherapy compared to WT AML in vivo. This evidence concerns the gene SELPLG and acute myeloid leukemia.